AU2001229367A1 - Genes differentially expressed in breast cancer - Google Patents

Genes differentially expressed in breast cancer

Info

Publication number
AU2001229367A1
AU2001229367A1 AU2001229367A AU2936701A AU2001229367A1 AU 2001229367 A1 AU2001229367 A1 AU 2001229367A1 AU 2001229367 A AU2001229367 A AU 2001229367A AU 2936701 A AU2936701 A AU 2936701A AU 2001229367 A1 AU2001229367 A1 AU 2001229367A1
Authority
AU
Australia
Prior art keywords
breast cancer
differentially expressed
genes differentially
seq
cancer cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229367A
Other languages
English (en)
Inventor
Greg Harrowe
Sanmao Kang
Joerg Kaufmann
Christoph Reinhard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AU2001229367A1 publication Critical patent/AU2001229367A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001229367A 2000-01-10 2001-01-09 Genes differentially expressed in breast cancer Abandoned AU2001229367A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17546200P 2000-01-10 2000-01-10
US60175462 2000-01-10
PCT/US2001/000899 WO2001051515A2 (en) 2000-01-10 2001-01-09 Genes differentially expressed in breast cancer

Publications (1)

Publication Number Publication Date
AU2001229367A1 true AU2001229367A1 (en) 2001-07-24

Family

ID=22640304

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229367A Abandoned AU2001229367A1 (en) 2000-01-10 2001-01-09 Genes differentially expressed in breast cancer

Country Status (9)

Country Link
US (1) US7605246B2 (enExample)
EP (2) EP1985701B1 (enExample)
JP (2) JP5250168B2 (enExample)
AT (1) ATE402258T1 (enExample)
AU (1) AU2001229367A1 (enExample)
DE (1) DE60134956D1 (enExample)
ES (2) ES2311016T3 (enExample)
PT (1) PT1248841E (enExample)
WO (1) WO2001051515A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081517B2 (en) * 2000-01-10 2006-07-25 Chiron Corporation Genes differentially expressed in breast cancer
DE102011110592A1 (de) 2011-08-18 2013-02-21 Rena Gmbh Verfahren zum Konditionieren von flachen Gegenständen
CN112837822B (zh) * 2020-09-24 2023-05-02 广州市疾病预防控制中心(广州市卫生检验中心、广州市食品安全风险监测与评估中心、广州医科大学公共卫生研究院) 预测covid-19患者发生轻至重度进展的标志物及试剂盒和建立方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
IE58011B1 (en) 1983-05-27 1993-06-16 Texas A & M Univ Sys Method for producing a recombinant baculovirus expression vector
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
ZA848495B (en) 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
US4837148A (en) 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
IL77186A0 (en) 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
DE68925971T2 (de) 1988-09-23 1996-09-05 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
FR2649120B1 (fr) 1989-06-30 1994-01-28 Cayla Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
WO1991016116A1 (en) 1990-04-23 1991-10-31 Cellpro Incorporated Immunoselection device and method
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
IT1254309B (it) 1992-02-17 1995-09-14 Uni Degli Studi G D Annunzio C Sequenze genetiche per l'antigene 90k associato a tumori.
EP0616802B1 (en) 1992-08-13 1998-06-17 Teikoku Seiyaku Co., Ltd. Oral preparation for release in lower digestive tracts
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
JP2003514543A (ja) * 1999-11-19 2003-04-22 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ２３個のヒト分泌タンパク質

Also Published As

Publication number Publication date
JP5250168B2 (ja) 2013-07-31
US7605246B2 (en) 2009-10-20
JP2003519480A (ja) 2003-06-24
ATE402258T1 (de) 2008-08-15
JP2012143242A (ja) 2012-08-02
ES2311016T3 (es) 2009-02-01
EP1985701A2 (en) 2008-10-29
EP1985701A3 (en) 2009-01-07
ES2386317T3 (es) 2012-08-17
DE60134956D1 (de) 2008-09-04
WO2001051515A2 (en) 2001-07-19
US20020004239A1 (en) 2002-01-10
EP1248841A2 (en) 2002-10-16
EP1248841B1 (en) 2008-07-23
EP1985701B1 (en) 2012-05-30
HK1118861A1 (en) 2009-02-20
WO2001051515A3 (en) 2002-01-24
PT1248841E (pt) 2008-09-15

Similar Documents

Publication Publication Date Title
AU1316200A (en) Metastatic breast and colon cancer regulated genes
WO1999034004A3 (en) Metastatic breast and colon cancer regulated genes
WO1999014327A3 (en) Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
WO1999035170A8 (en) Compositions and methods for the treatment of tumor
EP1623990A3 (en) Compositions and methods for the treatment of tumours
PL323632A1 (en) Dna sequence and ecoded breast carcinoma protein specific for mammary glands
WO2000053755A3 (en) Compositions and methods for the treatment of tumor
WO2002029086A3 (en) Nucleic acid sequences differentially expressed in cancer tissue
AU4851900A (en) Compositions and methods for the treatment of tumor
WO2003032813A3 (en) Methods for the treatment of carcinoma
WO2001009189A3 (en) Compositions and methods for the treatment of tumors
EP1642906A3 (en) Composition and methods for the diagnosis of tumours
WO2000015666A3 (en) Compositions and methods for the treatment of tumors
WO2000037640A3 (en) Compositions and methods for the treatment of tumor
AU2001229367A1 (en) Genes differentially expressed in breast cancer
AU1935399A (en) Nucleotide and protein sequence of mammastatin and methods of use
WO1998042830A3 (en) Noey2 gene compositions and methods of use
EP1693457A3 (en) Metastatic breast and colon cancer regulated genes
WO1999043812A3 (en) Dlc-1 gene, a putative tumors suppressor gene
WO2005049818A3 (en) Genes encoding human deubiquitinating enzymes
EP1201680A3 (en) Tumor suppressor polypeptide issued from CHC1-L (chromosome condensation 1-like)
EP1310556A3 (en) Composition and methods for the identification of lung tumor cells